Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
Merck Sharp & Dohme LLC
Marina C Garassino; Shirish Gadgeel; Giovanna Speranza; Enriqueta Felip; Emilio Esteban; Manuel Dómine; Maximilian J Hochmair; Steven F Powell; Helge G Bischoff; Nir Peled; Francesco Grossi; Ross R Jennens; Martin Reck; Rina Hui; Edward B Garon; Takayasu Kurata; Jhanelle E Gray; Paul Schwarzenberger; Erin Jensen; M Catherine Pietanza; Delvys Rodríguez-Abreu